Aras Azadian, the CEO of Avicanna, a multinational cannabis and biopharmaceutical company, is waiting in line at the passport office when he takes a call from The GrowthOp.
Story continues below
This advertisement has not loaded yet, but your article continues below.
Having recently returned from Mexico, where his passport was stolen, he’s got a day to resolve the situation before heading off again to Brazil.
“It’s part of the process of being CEO,” Azadian says, in a remarkably upbeat tone for someone waiting in line at the passport office.
Maybe it’s because Azadian is used to travelling, at least pre-pandemic. From its Toronto headquarters, Avicanna operates in the U.S., U.K. and Latin America, and has 480,000 square feet of
Read full article on The Growth Op
